Abstract
The objective of this study was to evaluate the efficacy of fluvoxamine in the treatment of pathological gambling. Thirty-two patients were treated for 6 months in a double-blind, placebo-controlled study of fluvoxamine 200 mg/day. Outcome measures included reduction in money and time spent gambling per week. Longitudinal mixed effects models and completers analyses were used for estimation and hypothesis testing. Fluvoxamine was not statistically significantly different from placebo in the overall sample. However, fluvoxamine was statistically significantly superior to placebo in males and in younger patients. The power of the study was limited by the high (59%) placebo-response rate. Fluvoxamine may be a useful treatment for certain subgroups of patients with pathological gambling. Several methodological recommendations are made for future pharmacological trials of pathological gambling.
Similar content being viewed by others
REFERENCES
National Research Council: Pathological Gambling: A Critical Review. Washington, DC: National Academy Press; 1999
Shaffer HJ, Hall MN, Vander BJ: Estimating the prevalence of disordered gambling behavior in the United States and Canada:Aresearch synthesis. Am J Pub Health 1999; 89:1369-1376
Lesieur HR, Rosenthal RJ: Pathological gambling: A review of the literature. J Gambling Stud 1991; 7:5-40
Hollander E, DeCaria C, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T: Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155:1781-1783
Kim SW, Grant JE, Adson DE, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49:914-921
Moreno I, Sáiz-Ruiz J, López-Ibor JJ: Serotonin and gambling dependence. Hum Psychopharmacol 1991; 6:S9-S12
DeCaria CM, Hollander E, Grossman R: Diagnosis, neurobiology and treatment of pathological gambling. J Clin Psychiatry 1996; 57(Suppl 8):80-84
Blanco C, Oresanz-Muñoz L, Blanco-Jerez C, Sáiz-Ruiz J: Pathological gambling and platelet MAO activity: Apsychobiological study. Am J Psychiatry 1996; 153:119-121
Pérez de Castro I, Ibáñez A, Sáiz-Ruiz J, Fernández-Piquereras J: Genetic contribution to pathological gambling: Association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics 1999; 9:397-400
Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, O'Malley SS: Gender differences in the characteristics of problems gamblers using a gambling helpline. Am J Psychiatry 2001; 158:1500-1505
Tavares H, Zilberman ML, Beites FJ, Gentil V: Gender differences in gambling progression. J Gambling Stud 2001; 17:151-159
Hollander E, DeCaria C, Finkell JN, Begaz T, Wong CM, Cartwright C: A randomized double-blind fluvoxamine/ placebo crossover trial in pathological gambling. Biol Psychiatry 2000; 47:813-817
Laird NM, Ware JH: Random effects models for longitudinal data. Biometrics 1982; 38:963-974
Diggle PJ, Liang K-Y, Zeger SL: Analysis of Longitudinal Data. Oxford: Clarendon; 1994
Haller R, Hinterhuber H: Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry 1994; 27: 129
Hollander E, Frankel M, DeCaria C, Trungold S, Stein DJ: Treatment of pathological gambling with clomipramine. Am J Psychiatry 1992; 149:710-711
Ricca V, Mannucci E, Mezzani B, Moretti S, Di Bernardo M, Bertelli M, Rotella CM, Favarelli C: Psychother Psychosom 2001; 70:298-306
Hollander E: Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Press; 1993
Kim SW, Grant JE: Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Res 2001; 104:205-212
Blanco C, Moreyra P, Nunes EV, Saiz-Ruiz J, Ibáñez A: Pathological gambling: Addiction or compulsion? Semin Clin Neuropsychiatry 2001; 6:167-176
Sylvain C, Ladouceur R, Boisvert JM: Cognitive and behavioral treatment of pathological gambling: A controlled study. J Consult Clinl Psychol 1997; 65:727-732
Miller RW, Rollnick S: Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford; 1991
Galanter M: Network Therapy for Alcohol and Drug Abuse: A new Approach in Practice. New York: Basic Books; 1993
Nunes EV: Methodologic recommendations for cocaine abuse clinical trials: A clinician-researcher's perspective. NIDA Res Monogr 1997; 175:73-95
Ibáñez A, Pérez de Castro I, Fernández-Piqueras J, Sáiz-Ruiz J: Sex differences in genetic contribution to pathological gambling. Am J Med Gen 1998; 81:523
Lesieur HR, Blume SB: When lady luck loses: The female pathological gambler. In: Van den BN, ed. Feminist Perspectives on Addictions. New York: Springer; 1991
McCormick RA, Russo AM, Ramírez LF, Taber JI: Affective disordersamongpathological gamblers seeking treatment. Am J Psychiatry 1984; 141:215-218
Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V, Barabaccia M, Guidotti A, Costa E, Linnoila M: Pathological gambling: A psychobiological study. Arch Gen Psychiatry 1988; 45:369-373
Bergh C, Eklund T, Sodersten P, Nordin C: Altered dopamine function in pathological gambling. Psychol Med 1997; 27:473-475
Roose SP, Suthers KM: Antidepressant response in late-life depression. J Clin Psychiatry 1998; 59(Suppl 10):4-8
Brown RIF: Classical and operant paradigms in the managament of gambling addictions. Behav Psychother 1987; 15:111-122
Brown RIF, Stewart RM: An outcome study of Gamblers Anonymous. Br J Psychiatry 1988; 152:284-288
Kelpsch R, Hand I, Wlazlo Z: Long-term effects of multimodal behavior therapy for pathological gamblers. Suchgefahren 1989; 35:35-49
Moskowitz JA: Lithium and lady luck: Use of lithium carbonate in compulsive gambling. NYS J Med 1980; 80:785-788
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blanco, C., Petkova, E., Ibáñez, A. et al. A Pilot Placebo-Controlled Study of Fluvoxamine for Pathological Gambling. Ann Clin Psychiatry 14, 9–15 (2002). https://doi.org/10.1023/A:1015215809770
Issue Date:
DOI: https://doi.org/10.1023/A:1015215809770